Tamoxifen for women at high risk of breast cancer

Safia A Nazarali, Steven A Narod Women's College Research Institute, Women's College Hospital, and The University of Toronto, Toronto, Ontario, Canada Abstract: Tamoxifen has been used as a treatment for women who have been diagnosed with breast cancer for roughly four decades and...

Full description

Saved in:
Bibliographic Details
Main Authors: Nazarali SA, Narod SA
Format: article
Language:EN
Published: Dove Medical Press 2014
Subjects:
Online Access:https://doaj.org/article/4f6dcb6d642a44e9ab0b890e2ff41d2a
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Safia A Nazarali, Steven A Narod Women's College Research Institute, Women's College Hospital, and The University of Toronto, Toronto, Ontario, Canada Abstract: Tamoxifen has been used as a treatment for women who have been diagnosed with breast cancer for roughly four decades and has been approved as chemoprevention for over ten years. Although tamoxifen has been proven to be beneficial in preventing breast cancer in high-risk women, its use has not been widely embraced. To some extent, this is due to several of its side effects, including an increased risk of endometrial cancer and pulmonary embolism, but these serious side effects are rare. The risks and benefits of tamoxifen chemoprevention should be considered for each patient. Keywords: tamoxifen, breast cancer, women, chemoprevention